Canagliflozin ameliorates ulcerative colitis via regulation of TLR4/MAPK/NF-κB and Nrf2/PPAR-γ/SIRT1 signaling pathways
Hanan S. Althagafy, Fares E.M. Ali, Emad H. M. Hassanein, Zuhair M. Mohammedsaleh, Mohamed I. Kotb El-Sayed, Ahmed M. Atwa, Ahmed M. Sayed, Ayman A. Soubh
Topics & Concepts
CanagliflozinPharmacologyChemistryUlcerative colitisInflammatory bowel diseaseInflammationColitisEndocrinologyMedicineInternal medicineType 2 diabetesDiabetes mellitusDiseaseHelicobacter pylori-related gastroenterology studiesAdenosine and Purinergic SignalingPancreatitis Pathology and Treatment